Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

William Blair Downgrades 10x Genomics to Market Perform

William Blair analyst Brian Weinstein downgrades 10x Genomics (NASDAQ:TXG) from Outperform to Market Perform.
byBenzinga Newsdesk
July 15, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

William Blair analyst Brian Weinstein downgrades 10x Genomics (NASDAQ:TXG) from Outperform to Market Perform.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts